Status:
UNKNOWN
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
Lead Sponsor:
Centre Antoine Lacassagne
Collaborating Sponsors:
University of Lyon
University of Firenze and Siena, Napoli, Italy
Conditions:
Neoplasms
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is an exploratory study aimed at characterizing adherence to the Mediterranean diet among patients undergoing treatment for cancer, in relation to sensory alterations that occur during treatment....
Eligibility Criteria
Inclusion
- Patient aged 18-70 years old,
- Patient cared for at the Center Antoine Lacassagne (CAL) Day Hospital and needing to start chemotherapy or immunotherapy,
- Patient to return to the Antoine Lacassagne center in their 9th week of therapy,
- Patient who has not received chemotherapy or specific treatment in the 3 months prior to inclusion (wash-out period of 3 months),
- Patient having read the information note and having attested to his non-objection
- Patient not having objected to the use of this data in the context of medical research
- Patient affiliated with a Social Security scheme.
Exclusion
- Inability to eat, or patient with enteral/parenteral nutrition,
- Patient who has undergone gastric surgery,
- Patient undergoing radiotherapy at the level of the ENT sphere (due to the possibility of affection of the mouth due to the RTH),
- Patient with cancer of the ENT sphere (upper aerodigestive tract),
- Patient with an allergy or intolerance to one of the foods offered during the sensory test sessions
- Vulnerable persons as defined in article L1121-5 to -8:
- Pregnant women, parturients and breastfeeding mothers,
- Persons deprived of their liberty by a judicial or administrative decision, persons hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8,
- and persons admitted to a health or social establishment for purposes other than research,
- Adults subject to a legal protection measure or unable to express their consent.
Key Trial Info
Start Date :
September 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 4 2024
Estimated Enrollment :
442 Patients enrolled
Trial Details
Trial ID
NCT06058312
Start Date
September 4 2023
End Date
September 4 2024
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine lacassagne
Nice, France, 06000